ARTICLE | Distillery Therapeutics
Therapeutics: Thrombopoietin receptor (CD110; Mpl)
October 29, 2015 7:00 AM UTC
Cell culture studies suggest autologous AML cells pretreated with a CD110 agonist antibody could help treat AML. A screen of 20 CD110 agonist antibodies in a primary AML cell-based differentiation ass...